'Switching Breast Cancer Drugs May Boost Survival (HealthDay)Switching to newer breast cancer drugs, called aromatase inhibitors, after two to three years of treatment with tamoxifen may extend disease-free survival and slightly reduce the risk of death in women who've been treated for early stage disease, an international study finds.
'Vitamin D Studies Show Promise for Reducing Cancers (HealthDay)Certain amounts of vitamin D may be able to prevent up to half of breast cancer cases and two-thirds of colorectal cancer cases in the United States, according to two studies by researchers at the Moores Cancer Center at the University of California, San Diego, and colleagues at other centers.